Olympia Pharmacy President Warns of Potential Peptide Shortage
Joshua Fritzler, president of Olympia Pharmacy, warned that the growing demand for peptides could exceed the industry's ability to supply them.
"We won't be able to meet demand," Fritzler said, adding that he doubts all 503A pharmacies across the country could collectively produce enough to satisfy demand.
The warning raises questions about supply capacity as interest in peptide-based treatments continues to grow.
For $HIMS, potential supply constraints could become an important factor to watch, depending on its exposure to affected products and sourcing arrangements.